{
    "ticker": "AVIR",
    "name": "Aviragen Therapeutics, Inc.",
    "description": "Aviragen Therapeutics, Inc. is a biotechnology company focused on the development of innovative antiviral therapies for the treatment of viral infections. Founded in 2010 and headquartered in Nashville, Tennessee, Aviragen is dedicated to addressing unmet medical needs in the field of infectious diseases. The company utilizes its proprietary technology platforms to discover and develop novel antiviral compounds targeting various viral pathogens, including influenza, respiratory syncytial virus (RSV), and others. Aviragen's lead product candidates include orally administered antiviral therapies designed to inhibit viral replication and enhance the immune response. The company's research and development efforts are supported by a team of experienced scientists and industry veterans committed to advancing the field of antiviral medicine. Aviragen aims to improve patient outcomes through the introduction of safe and effective treatments while navigating the complex landscape of clinical development and regulatory approval. The company's vision is to become a leader in antiviral therapeutics, leveraging cutting-edge science to create solutions that will have a meaningful impact on public health.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Nashville, Tennessee, USA",
    "founded": "2010",
    "website": "https://www.aviragen.com",
    "ceo": "Dr. William J. P. B. C. W. W. H. E. R. H. J. T. F. C. C. G. R. T. G. L. D. B. W. R. W. C.",
    "social_media": {
        "twitter": "https://twitter.com/Aviragen",
        "linkedin": "https://www.linkedin.com/company/aviragen-therapeutics"
    },
    "investor_relations": "https://www.aviragen.com/investors",
    "key_executives": [
        {
            "name": "Dr. William J. P. B. C. W. W. H. E. R. H. J. T. F. C. C. G. R. T. G. L. D. B. W. R. W. C.",
            "position": "CEO"
        },
        {
            "name": "Dr. Richard T. H. C. C. W. J. P. B. C.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Antiviral Therapies",
            "products": [
                "Aviragen's Influenza Treatment",
                "Aviragen's RSV Treatment"
            ]
        }
    ],
    "seo": {
        "meta_title": "Aviragen Therapeutics, Inc. | Innovative Antiviral Therapies",
        "meta_description": "Explore Aviragen Therapeutics, Inc., a biotechnology company dedicated to developing antiviral therapies for viral infections. Learn about their innovative products and commitment to public health.",
        "keywords": [
            "Aviragen",
            "Antiviral Therapies",
            "Biotechnology",
            "Pharmaceuticals",
            "Influenza Treatment",
            "RSV Treatment"
        ]
    },
    "faq": [
        {
            "question": "What does Aviragen Therapeutics specialize in?",
            "answer": "Aviragen Therapeutics specializes in developing antiviral therapies for the treatment of viral infections."
        },
        {
            "question": "Who is the CEO of Aviragen Therapeutics?",
            "answer": "The CEO of Aviragen Therapeutics is Dr. William J. P. B. C. W. W. H. E. R. H. J. T. F. C. C. G. R. T. G. L. D. B. W. R. W. C."
        },
        {
            "question": "Where is Aviragen headquartered?",
            "answer": "Aviragen is headquartered in Nashville, Tennessee, USA."
        },
        {
            "question": "What are Aviragen's main products?",
            "answer": "Aviragen's main products include antiviral treatments for influenza and RSV."
        },
        {
            "question": "When was Aviragen founded?",
            "answer": "Aviragen was founded in 2010."
        }
    ],
    "competitors": [
        "GILD",
        "MRNA",
        "NVAX"
    ],
    "related_stocks": [
        "AMGN",
        "BMY",
        "JNJ",
        "PFE"
    ]
}